Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer …

A du Bois, B Weber, J Rochon, W Meier… - Journal of clinical …, 2006 - ascopubs.org
Purpose Despite the progress that has been achieved, long-term survival rates in patients
with advanced ovarian cancer are still disappointing. One attempt to improve results could …
被引用次数：235 相关文章

Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer …

A du Bois, B Weber, J Rochon… - Journal of clinical …, 2006 - pubmed.ncbi.nlm.nih.gov
Purpose Despite the progress that has been achieved, long-term survival rates in patients
with advanced ovarian cancer are still disappointing. One attempt to improve results could …

[引用][C] Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer …

A DU BOIS - J Clin Oncol, 2006 - cir.nii.ac.jp
Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced
ovarian cancer : a prospectively randomized gynecologic cancer intergroup trial by the …

Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer …

A du Bois, B Weber, J Rochon, W Meier… - Journal of Clinical …, 2006 - europepmc.org
Purpose Despite the progress that has been achieved, long-term survival rates in patients
with advanced ovarian cancer are still disappointing. One attempt to improve results could …

[引用][C] Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: A prospectively randomized gynecologic cancer …

A DU BOIS, B WEBER, B RICHTER… - Journal of clinical …, 2006 - pascal-francis.inist.fr
Addition of epirubicin as a third drug to carboplatin- paclitaxel in first-line treatment of advanced
ovarian cancer : A prospectively randomized gynecologic cancer intergroup trial by the …

[引用][C] Addition of Epirubicin As a Third Drug to Carboplantin-Paclitaxel in First-Line Treatment of Advanced Ovarian Cancer: A Prospectively Randomized …

A DU BOIS - J Clin Oncol, 2006 - cir.nii.ac.jp
Addition of Epirubicin As a Third Drug to Carboplantin-Paclitaxel in First-Line Treatment of
Advanced Ovarian Cancer : A Prospectively Randomized Gynecologic Cancer Intergroup Trial …

[引用][C] Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: A prospectively randomized gynecologic cancer …

A DU BOIS, B WEBER… - Journal of …, 2006 - American Society of Clinical …